Compile Data Set for Download or QSAR

Found 109 hits of Enzyme Inhibition Constant Data   

TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193812(CHEMBL3908493)copy SMILEScopy InChI
Affinity DataIC50: 103nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193809(CHEMBL3890564)copy SMILEScopy InChI
Affinity DataIC50: 129nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193818(CHEMBL3925372)copy SMILEScopy InChI
Affinity DataIC50: 145nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193811(CHEMBL3951811)copy SMILEScopy InChI
Affinity DataIC50: 175nMAssay Description:Inhibition of EML4-ALK tyrosine phosphorylation in human NCI-H2228 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193814(CHEMBL3980825)copy SMILEScopy InChI
Affinity DataIC50: 200nMAssay Description:Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193808(CHEMBL3936443)copy SMILEScopy InChI
Affinity DataIC50: 200nMAssay Description:Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193817(CHEMBL3918616)copy SMILEScopy InChI
Affinity DataIC50: 240nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193808(CHEMBL3936443)copy SMILEScopy InChI
Affinity DataIC50: 382nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193822(CHEMBL3972807)copy SMILEScopy InChI
Affinity DataIC50: 403nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193815(CHEMBL3943236)copy SMILEScopy InChI
Affinity DataIC50: 435nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193814(CHEMBL3980825)copy SMILEScopy InChI
Affinity DataIC50: 508nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50389154(CHEMBL2064666)copy SMILEScopy InChI
Affinity DataIC50: 662nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193824(CHEMBL3961598)copy SMILEScopy InChI
Affinity DataIC50: 722nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193823(CHEMBL3934268)copy SMILEScopy InChI
Affinity DataIC50: 736nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193813(CHEMBL3934099)copy SMILEScopy InChI
Affinity DataIC50: 814nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193820(CHEMBL3943066)copy SMILEScopy InChI
Affinity DataIC50: 915nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetFocal adhesion kinase 1(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50389154(CHEMBL2064666)copy SMILEScopy InChI
Affinity DataIC50: 944nMAssay Description:Inhibition of FAK phosphorylation in human HCC827 cells after 2 to 2.5 hrs by immunoblot analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193819(CHEMBL3945332)copy SMILEScopy InChI
Affinity DataIC50: 994nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193816(CHEMBL3951972)copy SMILEScopy InChI
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193807(CHEMBL3961771)copy SMILEScopy InChI
Affinity DataIC50: 1.76E+3nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193825(CHEMBL3953048)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193811(CHEMBL3951811)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of INSR (unknown origin) by cell based assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193818(CHEMBL3925372)copy SMILEScopy InChI
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193813(CHEMBL3934099)copy SMILEScopy InChI
Affinity DataIC50: 3.70E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193811(CHEMBL3951811)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193810(CHEMBL3972653)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193811(CHEMBL3951811)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193811(CHEMBL3951811)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193810(CHEMBL3972653)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193810(CHEMBL3972653)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193810(CHEMBL3972653)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone/midazolam as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193810(CHEMBL3972653)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP1A2 in human liver microsomes using phenacetin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193811(CHEMBL3951811)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP1A2 in human liver microsomes using phenacetin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193811(CHEMBL3951811)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone/midazolam as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193814(CHEMBL3980825)copy SMILEScopy InChI
Affinity DataIC50: 7.90E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193808(CHEMBL3936443)copy SMILEScopy InChI
Affinity DataIC50: 9.10E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193814(CHEMBL3980825)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone/midazolam as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193815(CHEMBL3943236)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50389154(CHEMBL2064666)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50389154(CHEMBL2064666)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone/midazolam as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50389154(CHEMBL2064666)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193808(CHEMBL3936443)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193808(CHEMBL3936443)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone/midazolam as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50389154(CHEMBL2064666)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193808(CHEMBL3936443)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP1A2 in human liver microsomes using phenacetin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193814(CHEMBL3980825)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP1A2 in human liver microsomes using phenacetin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193808(CHEMBL3936443)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193811(CHEMBL3951811)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50193814(CHEMBL3980825)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D

Curated by ChEMBL
LigandPNGBDBM50389154(CHEMBL2064666)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2D79DC2PubMed
<< First | Previous | Displayed 51 to 100 (of 109 total ) | Next | Last >>* indicates data uncertainty>20%